Entrada Therapeutics's chart data is dated 2026-10-09. Recorded technical signals: Mean reversion. There are 0 published signal records.
Entrada Therapeutics last closed at $5.67 (+2.53%) on 2026-10-09. Signals today: Mean reversion. Listed on Nasdaq. Trailing 12 months PER is -1.4×. Its overall grade ranks 567 of 736 stocks in Healthcare.
About this company
Entrada Therapeutics last closed at $5.67 (+2.53%) on 2026-10-09. Signals today: Mean reversion. Listed on Nasdaq.
Details →Reported results
Position in sector
Healthcare · Overall C · 567/736
Valuation grade C+
Related stocks
- RocheCustomer
EntVivo/가나나-바이오 접합 기반 치료제 협력 및 개발 파트너로 알려짐
- GenentechCustomer
Entrada의 근육 질환 치료 후보 관련 공동개발/제휴 이력으로 연결
- Sarepta TherapeuticsCustomer
희귀 근육질환 치료제 분야에서 협력·파트너십 맥락의 주요 연결사로 자주 언급
About Entrada Therapeutics
- What technical signals does Entrada Therapeutics (TRDA) have?
- Entrada Therapeutics current technical signals: Mean reversion.
- Is Entrada Therapeutics a cup-and-handle pattern?
- No. Entrada Therapeutics has no valid Cup signal right now.
- What published figures are available for Entrada Therapeutics?
- Market cap: $216.7M. Trailing 12 months PER: -1.4×. Latest quarter PBR: 1.03×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Major stocks in the same sector
2026-10-10 dataset
Turn what you saw on this name into a strategy
Ask Q about Entrada Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.